Top 2% Travere Looks To Top Buy Zone After Screaming Up Another Beat

investors.com/news/technology/top-2-travere-looks-to-top-buy-zone-after-screaming-up-another-beat

Travere Therapeutics stock popped Friday — poising itself to top a buy zone — on another sales beat from its linchpin drug, Filspari.
The post Top 2% Travere Looks To Top Buy Zone After Screaming Up Another Beat appeared first on Investor's Business Daily.

This story appeared on investors.com, 2025-10-31 13:16:50.
The Entire Business World on a Single Page. Free to Use →